Related Experiment Video
Updated: May 2, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
The role of antiplatelet therapy in aneurysm coiling
Insights
Antiplatelet therapy is safe and effective for reducing thromboembolic risks during neurointerventional surgery for intracranial aneurysms. Further research is needed to minimize these risks, especially during aneurysm coiling.
Area of Science:
- Neurology
- Neurosurgery
- Cardiovascular Medicine
Background:
- Neurointerventional surgery enables advanced intravascular therapies for neurovascular diseases and stroke.
- Thromboembolism is a significant complication in neurointerventional procedures, particularly for intracranial aneurysms.
- Both antiplatelet and anticoagulant therapies are employed to mitigate thromboembolic risks.
Purpose of the Study:
- To review the role of antiplatelet therapy in the endovascular management of intracranial aneurysms.
- To assess the safety and efficacy of antiplatelet agents in reducing thrombotic risk.
- To evaluate the use of abciximab as a salvage therapy.
Main Methods:
- Literature review focusing on antiplatelet therapy in endovascular aneurysm treatment.
- Analysis of studies on pre-procedural and intra-procedural antiplatelet use.
- Examination of case reports and studies involving abciximab for thrombus management.
Main Results:
- Antiplatelet agents appear safe and effective for reducing thrombotic risk in unruptured aneurysms.
- Abciximab shows potential safety as a salvage therapy for thrombus formation in ruptured aneurysms with low hemorrhagic complication rates.
- Further innovation is required to enhance safety and reduce thromboembolic events in aneurysm coiling.
Conclusions:
- Antiplatelet therapy is a valuable tool in reducing thromboembolic complications during endovascular aneurysm treatment.
- Abciximab may serve as a safe option in specific scenarios of thrombus formation.
- Continued research is essential for optimizing neurointerventional strategies against thromboembolism.
Abstract:
Neurointerventional surgery offers the potential to deliver remarkable intravascular therapies for various neurovascular diseases and stroke. This approach, however, carries a risk of complications that need to be kept to a minimum. Thromboembolism is one of the most consequential complications of neurointerventional surgery in the treatment of intracranial aneurysms. Both antiplatelet and anticoagulant therapies have shown to reduce the risk of thromboembolism in this setting. In this paper, we review the role of antiplatelet therapy in the endovascular management of intracranial aneurysms. For unruptured aneurysms, the use of antiplatelet agents to pre-medicate patients before and during the procedure appears safe and effective in reducing the thrombotic risk. Abciximab has not been extensively studied, but seems to be safe as a salvage maneuver in the case of thrombus formation even in ruptured aneurysms (when the dome is relatively secure) with low rates of intraprocedure and procedure hemorrhagic complications. Further innovation and research are needed to further reduce thromboembolic risks of aneurysm coiling.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Aneurysm III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Aneurysm IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins

